Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Thymoma and thymic carcinoma
Results 1-15 of 15 for your search:
Start Over
A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: BBI608-201, NCI-2014-01566, NCT01325441
Vaccine Therapy and Iscomatrix with or without Cyclophosphamide and Celecoxib in Treating Patients with Thoracic Malignancies or Tumors That Have Spread to the Chest Cavity
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 14-C-0053, NCI-2014-02465, 140053, 348360, P131392, NCT02054104
Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CDKO-125a-006, NCI-2014-02427, 2009-014338-79, NCT01011439
Cisplatin, Doxorubicin Hydrochloride, Cyclophosphamide and Cetuximab Followed by Surgery in Treating Patients with Stage II-IVA or Recurrent Thymoma or Thymic Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 09-038, NCI-2010-00241, BMS #CA225-331, CA225-331, NCT01025089
Study Of Oral PHA-848125AC In Patients With Malignant Thymoma Previously Treated With Multiple Lines Of Chemotherapy
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CDKO-125a-007, NCI-2014-02428, NCT01301391
Targeted Enzyme Inhibitor Therapy in Treating Patients with Advanced Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Thymic Malignancies
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 11-C-0096, NCI-2013-01478, 110096, P10782, P8639_A15PAMDREVW01, 8639, NCT01306045
Plicamycin in Treating Patients with Malignancies Involving the Lungs, Esophagus, or Pleura That Cannot Be Removed by Surgery
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-C-0151, NCI-2013-01534, 120151, 319435, 348342, P12961, NCT01624090
Buparlisib in Treating Patients with Relapsed or Refractory Thymomas
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: IUCRO-0478, NCI-2014-01946, NCT02220855
Nintedanib and Prednisone in Reducing Radiation-Induced Pneumonitis in Patients with Thoracic Malignancies
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 14-167, NCI-2015-01232, NCT02496585
Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients with Locally Advanced Thoracic Malignancies
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: Pro00017361, NCI-2013-01246, Amd024_Pro00017361, CR006_Pro00017361, NCI-2010-01341, NCT00921739
Heated Cisplatin following Surgery in Treating Younger Patients with Primary or Metastatic Pleural Malignancies
Phase: Phase I
Type: Treatment
Age: 3 to 21
Trial IDs: 2012-0657, NCI-2014-01101, NCI-2014-00510, NCT01998529
Tissue Collection and Natural History Study of Patients with Non-small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, or Thymic Epithelial Tumors
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Tissue collection/Repository
Age: Over 18
Trial IDs: 14-C-0105, NCI-2015-01304, 334365, P131444, NCT02146170
Proton Beam Radiation Therapy in Treating Patients with Recurrent Thoracic Cancer Who Have Received Prior Radiation Therapy
Phase: No phase specified
Type: Treatment
Age: 19 and older
Trial IDs: 9148, NCI-2014-01468, NCT02204761
Online Coping Skills Curriculum in Improving Quality of Life in Cancer Patients and Survivors with Chronic Pain
Phase: No phase specified
Type: Supportive care
Age: 18 and over
Trial IDs: Pro00061381, NCI-2015-00756, NCT02465892
Start Over